CASTLE BIOSCIENCES INC Quarterly Depreciation in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Castle Biosciences Inc quarterly/annual Depreciation history and growth rate from Q2 2018 to Q3 2024.
  • Castle Biosciences Inc Depreciation for the quarter ending September 30, 2024 was $1.27M, a 40.7% increase year-over-year.
  • Castle Biosciences Inc Depreciation for the twelve months ending September 30, 2024 was $4.42M, a 47.6% increase year-over-year.
  • Castle Biosciences Inc annual Depreciation for 2023 was $3.32M, a 45.6% increase from 2022.
  • Castle Biosciences Inc annual Depreciation for 2022 was $2.28M, a 57.3% increase from 2021.
  • Castle Biosciences Inc annual Depreciation for 2021 was $1.45M, a 207% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.42M $1.27M +$367K +40.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $4.05M $1.1M +$309K +39% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $3.74M $1.09M +$423K +63.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $3.32M $953K +$326K +52% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $2.99M $902K +$285K +46.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $2.71M $792K +$261K +49.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $2.45M $670K +$167K +33.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $2.28M $627K +$185K +41.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $2.09M $617K +$222K +56.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $1.87M $531K +$153K +40.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $1.72M $503K +$270K +116% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $1.45M $442K +$282K +176% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $1.17M $395K +$276K +232% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $890K $378K +$276K +271% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $614K $233K +$142K +156% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $472K $160K +$60K +60% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $412K $119K +$28K +30.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $384K $102K +$16K +18.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $368K $91K +$14K +18.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $354K $100K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $91K +$16.5K +22.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $86K +$14.9K +21% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $77K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 $74.5K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $71.1K Apr 1, 2018 Jun 30, 2018 10-Q 2019-09-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.